Tiotropium safety in 'real-world' populations

被引：2

作者：

Wise, Robert ^{[1
]}

Anzueto, Antonio ^{[2
,3
]}

Dahl, Ronald ^{[4
]}

Dusser, Daniel ^{[5
]}

Calverley, Peter ^{[6
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA

[2] Univ Texas San Antonio, San Antonio, TX USA

[3] South Texas Vet Hlth Care Syst, San Antonio, TX USA

[4] Odense Univ Hosp, Odense C, Denmark

[5] Univ Paris 05, Sorbonne Paris Cite, Hop Cochin, AP HP,Serv Pneumol, Paris, France

[6] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2016年 / 82卷 / 02期

关键词：

RESPIMAT; TRIAL;

D O I：

10.1111/bcp.12972

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：562 / 563

页数：2

共 10 条

[1] Tiotropium in asthma: a systematic review [J].

Befekadu, Elizabeth ;

Onofrei, Claudia ;

Colice, Gene L. .

JOURNAL OF ASTHMA AND ALLERGY, 2014, 7 :11-21

[2] Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis [J].

Halpin, David M. G. ;

Dahl, Ronald ;

Hallmann, Christoph ;

Mueller, Achim ;

Tashkin, Donald .

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 :239-259

[3] Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease [J].

Miravitlles, Marc ;

Price, David ;

Rabe, Klaus F. ;

Schmidt, Hendrik ;

Metzdorf, Norbert ;

Celli, Bartolome .

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 :549-564

[4] Tiotropium Respimat® vs. HandiHaler®: real-life usage and TIOSPIR trial generalizability [J].

Schmiedl, Sven ;

Fischer, Rainald ;

Ibanez, Luisa ;

Fortuny, Joan ;

Thuermann, Petra ;

Ballarin, Elena ;

Ferrer, Pili ;

Sabate, Monica ;

Rottenkolber, Dominik ;

Gerlach, Roman ;

Tauscher, Martin ;

Reynolds, Robert ;

Hasford, Joerg ;

Rottenkolber, Marietta .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (02) :379-388

[5]

Tashkin D, 2014, EUR RESP J S58, V44, P923

[6] A 4-year trial of tiotropium in chronic obstructive pulmonary disease [J].

Tashkin, Donald P. ;

Celli, Bartolome ;

Senn, Stephen ;

Burkhart, Deborah ;

Kesten, Steven ;

Menjoge, Shailendra ;

Decramer, Marc .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) :1543-1554

[7] Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial [J].

Tashkin, Donald P. ;

Leimer, Inge ;

Metzdorf, Norbert ;

Decramer, Marc .

RESPIRATORY RESEARCH, 2015, 16

[8]

Wise R, 2015, EUR RESP SOC INT C S

[9] Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial [J].

Wise, Robert ;

Calverley, Peter M. A. ;

Dahl, Ronald ;

Dusser, Daniel ;

Metzdorf, Norbert ;

Mueller, Achim ;

Fowler, Andy ;

Anzueto, Antonio .

NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2015, 25

[10] Tiotropium Respimat Inhaler and the Risk of Death in COPD [J].

Wise, Robert A. ;

Anzueto, Antonio ;

Cotton, Daniel ;

Dahl, Ronald ;

Devins, Theresa ;

Disse, Bernd ;

Dusser, Daniel ;

Joseph, Elizabeth ;

Kattenbeck, Sabine ;

Koenen-Bergmann, Michael ;

Pledger, Gordon ;

Calverley, Peter .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (16) :1491-1501

← 1 →